Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support.
ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing
ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).